Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $78,983.88 -4.63%
Ethereum $2,428.77 -7.95%
BNB $779.91 -6.72%
Optimism $0.24 -5.43%
Arbitrum $0.14 -6.13%
Solana $105.53 -9.04%
Polygon $0.22 +2.77%
Cosmos $1.98 -2.71%
Avalanche $10.17 -3.71%

Bitcoin $78,983.88 -4.63%
Ethereum $2,428.77 -7.95%
BNB $779.91 -6.72%
Optimism $0.24 -5.43%
Arbitrum $0.14 -6.13%
Solana $105.53 -9.04%
Polygon $0.22 +2.77%
Cosmos $1.98 -2.71%
Avalanche $10.17 -3.71%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B